Indeed, in individuals with obesity and T2D, chronic low-grade inflammation, characterized by elevated IL-6 levels in various tissues, can contribute to reduced insulin sensitivity and impaired glucose metabolism [90]. This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.